Meeting Banner
Abstract #0255

The Feasibility of Evaluating Treatment Response of Bone Metastases by Segmenting Tumor Diffusion Volumes to Estimate Total Disease Burden on Whole Body Diffusion-Weighted Imaging

Matthew D. Blackledge1, Dow-Mu Koh1, Anwar R. Padhani2, James J. Stirling2, N J. Taylor2, David J. Collins1, Martin O. Leach1

1CR-UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; 2Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, London, United Kingdom

There is currently no standard for evaluating response of bone metastases to novel therapeutics, greatly inhibiting pharmaceutical development. In this feasibility study we investigate the role of tumour burden estimates and apparent diffusion coefficients measured using whole body diffusion weighted imaging (WBDWI) for monitoring treatment response. Good correlations are found between final clinical outcome in patients diagnosed with bone metastases and changes in median ADC value and tumour burden, as predicted using semi-automatic segmentation methods. It is concluded that such measurements from WBDWI will provide a useful tool in future clinical trials.